rs371978680

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.2382G>A​(p.Pro794Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,610,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.31

Publications

1 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 12-2585418-G-A is Benign according to our data. Variant chr12-2585418-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 238172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.31 with no splicing effect.
BS2
High AC in GnomAdExome4 at 22 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.2472G>A p.Pro824Pro synonymous_variant Exon 17 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.2547G>A p.Pro849Pro synonymous_variant Exon 18 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.2472G>A p.Pro824Pro synonymous_variant Exon 17 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.2472G>A p.Pro824Pro synonymous_variant Exon 17 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.2472G>A p.Pro824Pro synonymous_variant Exon 17 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.2472G>A p.Pro824Pro synonymous_variant Exon 17 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.2457G>A p.Pro819Pro synonymous_variant Exon 18 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.2457G>A p.Pro819Pro synonymous_variant Exon 18 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.2373G>A p.Pro791Pro synonymous_variant Exon 17 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.2382G>A p.Pro794Pro synonymous_variant Exon 17 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.*989G>A non_coding_transcript_exon_variant Exon 15 of 27 5 ENSP00000437936.2
CACNA1CENST00000480911.6 linkn.*989G>A 3_prime_UTR_variant Exon 15 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000206
AC:
5
AN:
242638
AF XY:
0.00000759
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000592
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000572
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000151
AC:
22
AN:
1458784
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
10
AN XY:
725382
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33472
American (AMR)
AF:
0.0000452
AC:
2
AN:
44252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39602
South Asian (SAS)
AF:
0.0000583
AC:
5
AN:
85718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1110532
Other (OTH)
AF:
0.0000332
AC:
2
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152184
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41462
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000302

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Aug 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 19, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.16
DANN
Benign
0.45
PhyloP100
-1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371978680; hg19: chr12-2694584; API